Guardion Health Sciences — Investor Presentation (May 2022)
17 slides from Guardion Health Sciences's investor presentation, May 4, 2022
Slide 1: Investor Presentation May 2022
Investor Presentation MAY 2022 Guardion is a company infused with motion and driven by innovation, working to improve quality of life through our clinical nutrition products. HEALTH SCIENCES
Slide 2: Forward Looking Statement
Forward Looking Statement This presentation of Guardion Health Sciences, Inc. (the “company,” “Guardion,” “we,” “us,” or “our”) includes "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These stat
Slide 3: Corporate Overview
Corporate Overview Guardion Health Sciences, Inc. (Nasdaq: GHSI), is a clinical nutrition company. Guardion’s portfolio of science-based, clinically supported nutrition, medical foods, and dietary supplements support healthcare professionals, their patients, and consumers in achieving health goals.
Slide 4: Highlights
GUARDION HEALTH SCIENCES Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health Well defined value creation process focused on clinical evidence, product development and t
Slide 5: Global Supplement and Medical Food Market
Global Supplement and Medical Food Market $153 Bn sd 050 CAGR = 7.9% Increasing awareness of the importance of nutrition Growing body of research demonstrating benefits of nutrition Increasing geriatric population with unique nutritional needs COVID-19 has made consumers more focused on Immune suppo
Slide 6: Well Defined Value Creation Process
Well Defined Value Creation Process 1 Strong Science & Clinical 2 Outstanding products 3 Target customer base Evidence drive formulations with impactful claims w/omni channel approach Customer Sci Clinical Targeted Needs Formulation Evidence Marketing Understand the Create science- Execute clinical
Slide 7: Leveraging Clinical Evidence
Leveraging Clinical Evidence e Guardion is leveraging and creating a science / evidence- based foundation through clinical studies to support our nutrition product portfolio e Investing in clinical research is fundamental to our model e New placebo-controlled clinical study initiated on Glaucocetin
Slide 8: Viactiv is a Strong Growing Brand with Potential for Expansion
@@ Giving you the strength to live each day co SHOP NOW actin & Mactiy < Viactiv® is a Strong Growing Brand with Potential for Expansion GUARDION HEALTH SCIENCES 3
Slide 9: Enthusiast Mindset
pd Enthusiast Mindset We call our target “ This is a psychographic } ies = Active, But Not Always Athletes ° Our core consumers like to be active, but they are not necessarily up at orin simpler terms—a mind: _ the crack of dawn training for a 10K. They often take their “activity” where they can get
Slide 10: Guardion Approach: What, Who, Why, How
GUARD ON HEALTH SCIENCES WHAT WHO WHY HOW EXPERT (Our approach to Clinical Nutrition Viactiv is “Science Powered. Experience Obsessed. Our experts actively select clinically proven ingredients. We design and deliver the best possible usage experience. Curious We fuel our expertise through hallenging
Slide 11: Core Products Achieve Superior Distribution
Core Products Achieve Superior Distribution Walmart>'< ©) TARGET amaz azon CVS pharmacy’ > ae Viactiv, MCKESSON GUARDION HEALTH SCIENCES "
Slide 12: Superior Consumer Experience
Superior Consumer Experience ® © @® No High Fructose Peanut/Tree Nut/ Corn Syrup Sesame Free Gluten Free No FD&C Dyes oe GUARDION HEALTH SCIENCES Specific claims vary by product 12
Slide 13: Organic Growth via Product Development & Commercialization
Organic Growth via Product Development & Commercialization e 10x more Omega-3 than leading DIETARY SUPPLEMENT. fish oil gummy* e Delicious Passion Fruit Gel Bites NN \ Vi © No Fish Burps ("1200 ms omesa-3 iam e Contains No Sugar aS e Enhance Absorption Oh) <7 nS \ ——< TOTAL BODY" PASSIONFRUIT FLAVOR
Slide 14: Management and Board of Directors
Bret Scholtes Susan Klein, ND Craig J. Sheehan Jeff Benjamin Liza Elder Chief Executive Officer Director of Chief Commercial Officer Chief Accounting Officer Brand Manager Board of Directors Medical Education 4 er | -_ i Robert N. Weingarten David W. Evans, PhD Donald A. Gagliano, MD Mark Goldstone
Slide 15: Financial Highlights
Financial Highlights Financial highlights for the year ended December 31, 2021 include the following: Total revenue increased to $7,233,118 in 2021, as compared to $1,889,844 in 2020, a 283% increase. Gross profit was $3,110,434 in 2021; gross loss was $(56,791) in 2020, such 2020 results being nega
Slide 16: Strategic Priorities — Driving Growth and Creating Value
Strategic Priorities — Driving Growth and Creating Value e Brand Strategy — by improving the management of our brand portfolio particularly, by leveraging Viactiv’s strong consumer awareness and acceptance e Product Strategy — continuing develop new products that increase our product breadth as well
Slide 17: Thank You
Thank You Guardion Health Sciences, Inc. (Nasdaq: GHSI), is a clinical nutrition company. Guardion’s portfolio of science-based, clinically supported nutrition, medical foods, and dietary supplements support healthcare professionals, their patients, and consumers in achieving health goals. The Compa
Guardion Health Sciences — Investor Presentation (May 2022) on 6ix